Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
低IgE結合性であり、T細胞抗原性の低下のない組換えアレルゲン
Document Type and Number:
Japanese Patent JP4508640
Kind Code:
B2
Abstract:
The present invention relates generally to reagents useful in the immunotherapeutic or immunoprophylactic treatment of allergic diseases. More particularly, the present invention provides modified allergens exhibiting reduced IgE interactivity including reduced IgE production-stimulatory activity, while retaining T-cell antigenicity, which are useful in the immunomodulation of type I allergic disease conditions. The present invention further contemplates a method of immunomodulation of allergic diseases such as type I allergic disease conditions by the administration of modified allergens exhibiting reduced IgE interactivity while retaining T-cell antigenicity.

More Like This:
WO/2021/000219BIOTIC STRESS TOLERANT PLANTS AND METHODS
WO/2002/018538PROTOCOLS FOR THE GENERATION OF HIGH YIELD, SUPER-PRODUCTIVE TRANSGENIC PLANTS DISTURBED IN Ran/Ran-BINDING PROTEINS-MEDIATED CELLULAR PROCESS
WO/2002/083715METHOD AND APPARATUS FOR FRACTIONAL SEPARATION OF PROTEINS FROM PLANT MATERIAL
Inventors:
Deweed Nicole
Shin, Mohan, Beer
Barra, Prem, Elle.
Swoboda, Ines
Application Number:
JP2003528855A
Publication Date:
July 21, 2010
Filing Date:
September 13, 2002
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
The University of Melbourne
International Classes:
C07K14/415; A61K39/36; C12N15/09; A61P37/08; C07K16/16; C12N15/13
Domestic Patent References:
JP8509966A
JP2002511842A
JP2002542783A
Other References:
Int. Arch. Allergy Immunol., 2001年1-3月(国立国会図書館, 2001年5月23日受入), vol. 124, p. 380-382
Mol. Immunol., 1998年4月, vol. 35, on. 5, p. 293-305
Eur. J. Immunol., 2002年, vol. 32, p. 270-280
Attorney, Agent or Firm:
Mizuno Yuuki



 
Previous Patent: ミューラー管抑制物質のレベルおよび卵巣の応答

Next Patent: テンショナ